TGFB1 and breast carcinoma: Interestingly, as determined in breast cancer datasets (Fig. 1h), enhanced TGF-β signaling activity was also positively correlated with increased sEV secretion in vitro as quantified by total sEV protein through BCA assay (Fig. 2b and Supplementary Fig. 3a).